Ataxia telangiectasia: why should the ERS care?

Jayesh M. Bhatt*, Andrew Bush, Marjo van Gerven, Andreea Nissenkorn, Michael Renke, Lian Yarlett, Malcolm Taylor, Thorny Tonia, Adilia Warris, Stefan Zielen, Shairbanu Zinna, Peter J. F. M. Merkus

*Corresponding author for this work

Research output: Contribution to journalEditorial

3 Citations (Scopus)

Abstract

Neurological and immunological contributions to lung disease in A-T require proactive and multidisciplinary management http://ow.ly/TqT44

Why indeed should we care? The answer is that ataxia telangiectasia (A-T) patients will present to respiratory paediatricians for diagnosis, when standard testing, if the diagnosis is not made, may do irreparable harm; and both adult and paediatric respiratory physicians will be involved in managing the respiratory disease, which is a major cause of morbidity and mortality. So there is a real “need to know” which is why the ERS convened a task force on A-T, whose findings are published in the European Respiratory Review [1].
Original languageEnglish
Pages (from-to)1557-1560
Number of pages4
JournalEuropean Respiratory Journal
Volume46
Issue number6
Early online date30 Nov 2015
DOIs
Publication statusPublished - 1 Dec 2015

Keywords

  • lung-disease
  • nutritional-status
  • immunodeficiency
  • infections
  • deficiency
  • child

Cite this

Bhatt, J. M., Bush, A., van Gerven, M., Nissenkorn, A., Renke, M., Yarlett, L., Taylor, M., Tonia, T., Warris, A., Zielen, S., Zinna, S., & Merkus, P. J. F. M. (2015). Ataxia telangiectasia: why should the ERS care? European Respiratory Journal, 46(6), 1557-1560. https://doi.org/10.1183/13993003.01456-2015